Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

ResMed Boosts Its Dividend


ResMed (NYSE: RMD), a medical device company focused on breathing disorders, reported its fiscal fourth-quarter and full-year 2019 results on Thursday.

Revenue grew 13% when compared to the year-ago period, which represents yet another sequential acceleration on a sequential basis. However, expenses remain elevated as the company continues to integrate a handful of recent acquisitions. The net result is very little growth on the bottom line.

Metric

Continue reading


Quelle Fool.com

Like: 0
RMD
Share

Comments